Uncategorized

Researchers claim that water fluoridation is less harmful to the environment than other tooth decay prevention techniques. The study’s results further support the need for water fluoridation programmes to reduce dental decay, especially in the most susceptible populations.

Fluoridation of water has been hailed as one of the most important 20th-century public health initiatives. The role of healthcare and disease prevention in the climate catastrophe, however, must be investigated as it gets worse. The time for action is now. This urgency led researchers to estimate the environmental effects of water fluoridation for a single five-year-old child over the course of a year. They did this by drawing comparisons to the conventional application of fluoride varnish and toothbrushing campaigns, both in the UK and overseas.

Today, fluoridated water is available to more than 35% of the world’s population, and studies show that tooth decay has significantly decreased. There is currently no proof of the environmental effects of water fluoridation, despite statistics on the clinical efficacy and cost-benefit analyses being accessible.

The research team methodically calculated the combined travel, weight, and quantities of all objects and activities engaged in all three preventative programmes in order to conduct a Life Cycle Assessment (LCA) to evaluate this impact (toothbrushing, fluoride varnish programmes, and water fluoridation). The team used the Ecoinvent database to determine environmental outputs like carbon footprint, the amount of water needed for each product, and land use. Data were placed into a specific environmental application (OpenLCA).

The results of the study, which were led by Brett Duane, Associate Professor in Dental Public Health at Trinity College, showed that water fluoridation had the least adverse effects on the environment of all the categories examined and the least adverse effects on disability-adjusted life years of all the community-level caries prevention programmes. The study also found that fluoridating drinking water offers the best return on investment.

Due to the balance of clinical effectiveness, financial effectiveness, and environmental sustainability, researchers believe that water fluoridation should be the preventative intervention of choice.

This study strengthens the argument for water fluoridation programmes around the world to reduce dental decay, especially in the most vulnerable populations.

“As the climate situation increases, we must identify techniques to prevent disease in order to decrease the environmental impact of our health-care systems,” said Associate Professor Duane. This study unequivocally demonstrates that water fluoridation is an efficient preventative measure with a minimal carbon footprint.

There should be increased efforts to encourage access to this technique, said Professor Paul Ashley, Senior Clinical Lecturer (Honorary NHS Consultant) at the University College London Eastman Dental Institute.

According to medical professionals, the post-COVID syndrome, which apparently started after the second wave of the virus, has led to an increase in heart and neurological issues. Dr. Devi Prasad Shetty, the Chairman of Narayana Health and an Executive Director, stated that there was an increase in brain and heart-related problems during the second wave, but that more information is needed in the current situation.

“There was obviously a minor increase in the incidence of COVID patients acquiring clot formations, and clots in the brain or in the heart, particularly during the second wave. However, we didn’t notice that pattern until the second wave.

We need to gather more data before we can determine whether this is actually the case, but we did observe a somewhat greater incidence of cardiac issues and brain stroke “said Dr. Shetty.

However, the research on the function of COVID in causing acute cardiac issues following recovery is still in its early stages, according to Dr. Nitish Naik, Professor, Department of Cardiology, AIIMS, Delhi.

“There has always been a higher risk of cardiac health problems with any flu-like conditions. This has long been known, and Covid is acting in a manner that is consistent with it. Our understanding of how Covid 19 contributes to acute cardiac issues that develop after recovery is still developing.

According to Dr. Arun Sharma, a Senior Consultant Neurosurgeon at the Indian Spinal Injuries Center, those who have experienced COVID are more likely to experience neurological diseases.
“Patients who have experienced Covid are more likely to have neurological problems. Young individuals suffering from stroke are arriving in large numbers. Additionally, there has been an upsurge in mental health problems. The population is increasingly experiencing psychological problems, “The doctor remarked.
“Only mild to moderate activity and regular relaxation breathing activities (Pranayama/meditation) are indicated for people. Their stress levels will decrease at work and at home as a result “He continued by outlining some preventative actions.

According to Dr. Manjari Tripathi, a professor of neurology at AIIMS, the impact of post-COVID neurological illnesses on the brain has led to an increase in these conditions.

“There is little doubt that post-COVID-19 neurological diseases are increasing due to effects on the brain, including memory loss, dementia, strokes, Guillain-Barre syndrome, a severe neuropathy, and worsening seizures and epilepsy. Therefore, this is well-known from a neurological perspective. Indeed, the heart is also impacted. Younger people are having heart attacks and more myocarditis is present, according to the patient statistics, he noted.

Dr. Tripathi advised the patients to start their medicine and get checked to see if they had any neurological issues.

“As soon as there is even a slight amount of discomfort, such as some symptoms or chest pain, recommendations are made for these. They shouldn’t be confused with indigestion, and you should get checked out. Naturally, for neurological issues, the patient should visit the doctor, get tested for memory complaints, and start taking the appropriate medicine. This is especially true if the patient is obese and has obstructive sleep apnea “She recommended.

A recent study reveals that the sleep-related brain activity of young people with genetic changes that raise the risk of psychiatric disorders differs significantly from that of healthy young people.

1 in 3000 births result in 22q11.2DS, which is brought on by a gene loss of about 30 genes on chromosome 22. It raises the chance of epileptic seizures, autism spectrum disorder (ASD), intellectual disability, and attention-deficit hyperactivity disorder (ADHD). Additionally, it ranks highly among the biological risk factors for schizophrenia. Uncertainty surrounds the molecular processes that underlie the psychological symptoms of 22q11.2DS, though.

According to co-senior author Marianne van den Bree, Professor of Psychological Medicine at Cardiff University, UK, “We have recently shown that the majority of young people with 22q11.2DS have sleep problems, particularly insomnia and sleep fragmentation, that are linked with psychiatric disorders.” The neurophysiology—what is happening to brain activity—has not yet been investigated because our earlier investigation was based on parents reporting on their children’s sleep quality.

An electroencephalogram is a recognised method of assessing brain activity while you are sleeping (EEG). This monitors electrical activity as you sleep and includes spindle and slow-wave (SW) oscillation patterns. These characteristics of non-rapid eye movement (NREM) sleep are thought to support the development of the brain and memory.

According to co-senior author Marianne van den Bree, Professor of Psychological Medicine at Cardiff University, UK, “We have recently shown that the majority of young people with 22q11.2DS have sleep problems, particularly insomnia and sleep fragmentation, that are linked with psychiatric disorders.” The neurophysiology—what is happening to brain activity—has not yet been investigated because our earlier investigation was based on parents reporting on their children’s sleep quality.

An electroencephalogram is a recognised method of assessing brain activity while you are sleeping (EEG). This monitors electrical activity as you sleep and includes spindle and slow-wave (SW) oscillation patterns. These characteristics of non-rapid eye movement (NREM) sleep are thought to support the development of the brain and memory.

Lead author Nick Donnelly, Clinical Lecturer in General Adult Psychiatry at the University of Bristol, UK, said: “Sleep EEG is known to be disrupted in many neurodevelopmental diseases, and the characteristics and coordination of these abnormalities can be utilised as biomarkers for psychiatric dysfunction.”

In order to investigate this in 22q11.2DS, the team recruited 28 children between the ages of 6 and 20 who had the chromosome deletion as well as 17 siblings who were unaffected as part of the Cardiff University Experiences of Children with Copy Number Variants (ECHO) study, which is headed by Prof. van den Bree. They examined the relationships between mental symptoms and sleep EEG patterns, as well as how well the subjects performed in a morning recall test.

They discovered that, in comparison to their siblings, the group with 22q11.2DS showed substantial differences in their sleep patterns, with higher proportions of N3 NREM sleep (slow-wave sleep) and lower proportions of N1 (the first and lightest sleep stage) and rapid eye movement (REM) sleep. Additionally, those who had the chromosomal deletion had higher slow-wave oscillation and spindle EEG power. Additionally, there was a tighter link between the spindle and slow-wave EEG features and an increase in the frequency and density of spindle patterns in the 22q112.DS group. The connections inside and between the cortex and thalamus, the brain regions that produce these oscillations, may have changed as a result of these modifications.

Before going to bed, participants had to remember where matching cards were on a screen for a 2D object finding test. The group discovered that higher spindle and SW amplitudes were related to decreased accuracy in those with 22q11.2DS when they were assessed again on the identical task in the morning. In contrast, higher amplitudes were associated with greater accuracy in the morning memory test in persons who did not have the chromosomal deletion.

Finally, the team used a statistical technique known as mediation to calculate the effect of the variations in sleep patterns on psychiatric symptoms in the two groups.

They determined the overall impact of genotype on IQ and psychiatric measurements, as well as the indirect (mediated) impact of EEG measurements. Finally, they computed the percentage of the overall impact that might be mediated by EEG patterns. They discovered that the 22q11 was responsible with the impacts on anxiety, ADHD, and ASD. 2 deletion were mediated in part by variations in sleep EEG.

According to co-senior author Matt Jones, Professorial Research Fellow in Neuroscience, University of Bristol, UK, “our EEG findings collectively suggest a complex picture of sleep neurophysiology in 22q11.2DS and highlight differences that could serve as potential biomarkers for 22q11.2DS-associated neurodevelopmental syndromes.”

In order to identify signs of brain circuit failure that could let doctors know which patients are more at risk and support treatment choices, more research is now required to define the association between mental health symptoms, sleep EEG measurements, and neurodevelopment.

In Pakistan, where monsoon rains and floods continue to wreak havoc on people’s lives and resources, analysts have asserted that climate change has a severe impact on women, who carry the majority of the burden of catastrophes in terms of psychological and reproductive health.

A study found that women are more affected than males are by climate change-related events, such as floods and storms. According to a study named “Understanding Climate Change, Impact on Women’s Reproductive Health: Post-Disaster Interventions in Sindh,” there is data demonstrating connections between climate change, health, and sexual and reproductive health and rights (SRHR).

Mehmil Khalid, writing for Dunyanews, highlighted the report and stated that the lack of means to feed themselves and the lack of basic facilities, on which women are heavily dependent to operate a home, leaves them stuck pitifully.

The majority of women who work in agriculture in flood-affected areas suffer from considerable yield loss, which results in food insecurity and severe malnutrition in their bodies. Since they are forced to confine themselves in camps without access to food and water, women who lack resources often experience stress and psychological problems.

“Women who are pregnant and girls are more susceptible to psychological anxieties. While living in camps, women and girls experienced psychological fear and insecurity “the report claims.

Experts have observed that during floods, women experience significant reproductive health difficulties.

Due to serious problems and a lack of medical services to provide immediate treatment, some women die or their infants die.

Due to rigid gender barriers and male dominance, the majority of women are reluctant to practise self-aid. In times of dire need, they are confined to their camps and are not permitted to leave if they need assistance.

According to Khalid, women frequently have financial difficulties when their husbands pass away in flood-prone areas or even after they leave since they lack the tools to secure their financial future.

When calamities strike, domestic violence also increases, costing men their livelihoods and adding to their already high levels of frustration.

When they were unable to gather enough resources to scratch out a life, men would beat women in their encampment. They vent their resentment on their ladies because they think they are naturally tolerant and able to handle it. According to Dunyanews, it has been discovered that the subsequent relocations lead to an upsurge in occurrences of domestic and sexual abuse against women, leaving them defenceless and at the whim of their husbands.

According to analysts, if the government concentrated on disaster risk prevention and rigorously invited investments in adaptation and planned rehabilitation of people in advance in case of an emergency, the destruction caused by flash foods may be averted.

They urged the introduction of gender-sensitive legislation, the teaching of women life-saving skills, and the setting up of improved revenue production options as ways to empower women, lessen their vulnerability.

Future climate change-related disasters will become more severe and can only be prevented by implementing sustainable policies and climate change adaption strategies as soon as possible.

Analysts also emphasised the necessity for women to be given decision-making positions and encouraged to take part in developing logical solutions for issues related to climate change, which can lower the dangers involving women.

“Women interventions in cases involving women’s issues are vital in bringing about favourable outcomes and speedy fixes for difficulties that they encounter,” According to Dunyanews, who cited analysts.

Notably, the country’s National Disaster Management Authority reports that 937 people have perished in the South Asian nation since mid-June as a result of heavy rain and flooding (NDMA).

One million tents have been sought for Sindh in the south, which has been severely affected by the flooding, while 100,000 tents have been requested for neighbouring Balochistan. According to the NDMA’s most recent situation assessment, since the start of the monsoon, more than 3,000 kilometres (1,864 miles) of road, 130 bridges, and 495,000 dwellings have suffered damage.

The World Health Organization (WHO) has warned of serious public health threats facing affected populations, including the risk of further spread of water and vector-borne diseases like malaria and cholera, as districts in Pakistan continue to be affected by intense monsoon rainfall and unprecedented levels of flooding.

Millions of people lack access to medical care and treatment as a result of the country’s approximately 888 damaged health facilities, 180 of which are entirely ruined, according to reports from many impacted districts.

A significant finding has been made by researchers who are creating oral insulin tablets to replace daily insulin injections. Researchers have found that rats absorb insulin from the most recent iteration of their oral tablets in a manner similar to that of insulin administered intravenously.

Professor Dr. Anubhav Pratap-Singh (he/him), the principal investigator from the faculty of land and food systems, says, “These exciting results show that we are on the right track in developing an insulin formulation that will no longer need to be injected before every meal, improving the quality of life, as well as mental health, of more than nine million Type 1 diabetics around the world.”

He reveals that his diabetic father, who has been injecting insulin three to four times a day for the past 15 years, served as the motivation for his hunt for a non-injectable insulin.

The senior fellow in Dr. Pratap-lab, Singh’s Dr. Alberto Baldelli (he/him), claims that they are currently observing nearly 100% of the insulin from their tablets move directly into the liver. In earlier attempts to create an insulin that could be drank, the majority of the insulin would build up in the stomach.

“We did not discover any insulin in the stomachs of the rats we tested, not even two hours after delivery.

According to Yigong Guo (he/him), the study’s primary author and a PhD candidate who worked closely on the project, it was all in the liver, which is the perfect target for insulin.

Changing the delivery method

Injections are not the most convenient or comfortable method for diabetic sufferers to receive their insulin. However, the UBC team tried to determine where and how to enable a higher absorption rate in light of the fact that a number of different oral insulin substitutes were also being researched and produced.

A second form of tablet, created by Dr. Pratap-team, Singh’s dissolves when put between the gum and cheek rather than being swallowed.

The thin membrane that lines the inner cheek and rear of the lips is used in this procedure (also known as the buccal mucosa). It transported all of the insulin to the liver without wasting or degrading any of it.

“We typically need 100iu of injectable insulin every injection. Another issue we’ve been attempting to solve is that other ingested pills being created that go to the stomach may require 500iu of insulin, which is largely squandered.

Fast-release injectable insulin can be fully released in 30-120 minutes, but the majority of oral insulin tablets in development tend to release insulin slowly over two to four hours.

According to Dr. Baldelli, “our oral delivery tablet absorbs after half an hour and can last for roughly two to four hours long.” rapid-acting insulin injection.

Possibile large advantages

Human trials for the investigation have not yet begun, and according to Dr. Pratap-Singh, they will need additional time, money, and colleagues before they can begin. Beyond the obvious potential advantages for diabetics, he claims that the tablet they are developing might also be more accessible, affordable, and sustainable.

According to Dr. Pratap-Singh, more than 300,000 Canadians must inject insulin many times daily.

There would be no issue with an oral tablet, but there would be a lot of environmental waste from the needles and plastic from the syringe that might not be recycled and end up in a landfill.

He notes that they are hoping to lower the price of insulin per dosage since their oral substitute may be less expensive and simpler to produce. For diabetics who presently have to think about keeping their doses cool, transporting the tablets would be simpler.

Researchers from Saint Louis University School of Medicine and Washington University School of Medicine in St. Louis discovered that guys with COVID-19 who had low testosterone levels were more likely to have severe illness and need hospitalisation than those with normal levels.

The study looked at 723 people who tested positive for COVID-19, mostly in 2020 before vaccines were available. According to the findings, low testosterone is an independent risk factor for COVID-19 hospitalisation, just like diabetes, heart disease, and chronic lung disease. They found that males who tested positive for COVID-19 and had low testosterone were 2.4 times more likely to require hospitalisation than men who tested positive for COVID-19 and had hormone levels that were within the normal range.

Men who had successfully had hormone replacement therapy but had testosterone levels that had traditionally tested within the normal range were not any more likely to be hospitalised for COVID-19 than were men whose testosterone levels had consistently tested within the normal range.

The findings suggest that treating low testosterone in boys may protect them from serious disease and minimise the burden on hospitals during COVID-19 waves. They were published on September 2 in JAMA Network Open.

Abhinav Diwan, MD, a co-senior author and professor of medicine at Washington University, believes that COVID-19 is most likely here to stay. Diwan practises medicine at Barnes-Jewish Hospital and teaches cell biology and physiology and obstetrics and gynaecology.

Hospitalizations due to COVID-19 are still a problem and will continue to be so as long as the virus keeps evolving novel forms that circumvent vaccination-based immunity. Low testosterone is a moderately common disorder that affects up to one-third of guys over the age of 30. Our study emphasises the importance of this risk factor and the need to address it in order to decrease hospitalizations.

Prior research by senior author Diwan and co-author Sandeep Dhindsa, an endocrinologist at Saint Louis University, has shown that males hospitalised with COVID-19 have abnormally low testosterone levels. A severe illness or stressful event, however, may momentarily reduce hormone levels.

Data from men who have already been hospitalised with the disease have not been very helpful in determining whether low testosterone is a risk factor for severe COVID-19 or its effect. The goal of the study was to determine whether those with chronically low levels of testosterone were more prone to disease than people with normal amounts.

Co-author Cosette Champion, MD, a Barnes-Jewish internal medicine resident, together with colleagues Diwan and Dhindsa, reviewed patient records at two important hospital systems in the St. Louis area: SSM Health and BJC HealthCare. They discovered 723 males who had their testosterone levels checked between January 1, 2017, and December 31, 2021, and who had COVID-19 instances that had been reported in 2020 or 2021.

The patient’s testosterone levels were occasionally assessed after COVID-19 recovery. According to Dhindsa, since low testosterone is a chronic condition, men who tested low a few months after recovering from COVID-19 likely had low testosterone levels earlier as well.

The study discovered 180 men who had previously had low testosterone levels but had been effectively treated, 116 men with low testosterone levels, and 427 men with normal testosterone levels. At the time they developed COVID-19, these guys were getting hormone replacement treatment, and their testosterone levels were within the normal range.

According to Dhindsa, low testosterone was discovered to be a risk factor for COVID hospitalisation, however therapy decreased that risk.

“The risk drastically increases below 200 nanograms per deciliter, while the normal range is 300 to 1,000 nanograms per deciliter. Age, obesity, and the other conditions we examined as risk factors have no impact on this. The risk for those receiving therapy, however, is constant.

Men who have low testosterone may experience sexual dysfunction, low mood, irritability, memory loss, weariness, loss of muscular mass, and a generalised diminished sense of well-being. Male patients are typically treated with testosterone replacement therapy when their quality of life is plainly suffering. However, people and medical professionals may be reluctant to treat when the symptoms are mild.

The two primary problems with testosterone therapy are the risk of heart disease and prostate cancer. Prostate cancer, which is typically driven by testosterone, frequently strikes older men. Increasing testosterone may hasten the onset of some cancers, worsening the illness. Less is known about heart disease risk factors. A significant scientific study on the relationship between testosterone supplements and heart health is expected to be completed soon.

According to Diwan, a trained cardiologist, “our findings would suggest that it would be prudent to look at testosterone levels, especially in patients who have low testosterone symptoms, and then individualise care.”

The doctor could discuss the benefits and drawbacks of hormone replacement therapy with the patient if they have a particularly high risk of cardiovascular events. One possible benefit could be a decreased risk of COVID hospitalisation.

Diwan cautioned that as the research was observational, it is not possible to draw any conclusions about whether raising testosterone levels can save men from getting severe COVID-19. To conclusively show whether such a method is beneficial, a clinical trial would be necessary.

Using stem cells, researchers were able to create a brand-new variety of human cell in the lab. The new cells mimic early human embryonic equivalents found in nature very closely. As a result, scientists are better able to understand what occurs right after an embryo implants in the womb.

A human embryo should implant in the womb seven days after fertilisation if all goes according to plan. Due to legal and moral restrictions, the embryo is thus inaccessible for research. To investigate human development in a dish, scientists have previously created stem cell models for a variety of embryonic and extraembryonic cell types.

Extraembryonic mesoderm cells are a particular form of human embryonic cell, and Vincent Pasque’s team at KU Leuven has created the first model for these cells. Academician Pasque: “These cells help to bind the embryo to the developing placenta, produce the first blood in an embryo, and contribute to the formation of the early umbilical cord. There may be other significant differences between the two species in addition to the fact that this type of cell first occurs in human embryos sooner than it does in mouse embryos. Because research on mice may not provide us with conclusions that also hold true for people, this makes our model all the more crucial.”

The scientists used human stem cells, which can still differentiate into every variety of embryonic cell, to create their model cells.

The new cells are a useful model for that particular cell type since they closely match their natural counterparts in human embryos.

Pasque explains, “You don’t create a new human cell type every day. “Because we can now examine processes that are often inaccessible during development, we are really happy about this. In reality, we have already been able to determine the origin of extraembryonic mesoderm cells thanks to the model. Longer term, our model should also help to better understand medical issues like infertility, miscarriages, and developmental diseases.”

Massive amounts of donated lungs cannot be transplanted. A recent animal study conducted by scientists at Lund University and Skane University Hospital in Sweden raises the prospect of using more donor lungs in the future. The researchers have initiated a pilot trial to see if the medication would have the same positive effect on people.

Each year, approximately 190 organs are donated in Sweden. Due to lung deterioration, only about 30% of the lungs can be used for transplantation. The mortality rate is also increased by the fact that a sizable portion of patients pass away five years following transplantation.

Our study’s findings, according to Sandra Lindstedt, senior consultant in thoracic surgery at Skane University Hospital and adjunct professor at Lund University, “indicate that there is an improved outcome during the first two days after surgery and that a specific treatment can help us use a larger part of a donor’s lung.”

In their examination, the researchers looked at the outcomes of reducing the cytokine concentrations in pigs’ lungs. Certain immune system cells produce tiny proteins called cytokines.

Acute respiratory distress syndrome was caused by a decreased lung capacity prior to the transplant (ARDS). The outcome was that the lungs were damaged, just like human donor lungs would be.

In ten of the cases, the donor lung was treated, either before and after the transplant or immediately afterwards. Six instances made comprised the control group, which got no therapy.

The results show that the recovery of lung function to a higher level than before was caused by the lower levels of cytokines. Furthermore, according to Sandra Lindstedt, “We could tell that the lungs were operating better after the transplant and those difficulties during the first 48 hours after transplant was reduced.

About 50 to 60 lung transplants are performed each year at Sahlgrenska University Hospital in Gothenburg and Skane University Hospital in Lund. The number is anticipated to rise as a result of the new treatment.

The lives of those who are waiting for transplants may be significantly improved if we can utilise this on some of the donor lungs that are currently discarded, even though it won’t work on every donor’s lung. We want to provide the foundation for greater patient survival, says Sandra Lindstedt.

In order to conduct the study, a specialist unit was set up within the Department of Cardiothoracic and Vascular Surgery, Anaesthesia, and Intensive Care at Skane University Hospital. The unit contained all of the study-related abilities.

This study would not have been possible without the major contributions of various clinical specialties, including thoracic surgeons, anesthesiologists, perfusionists, operating room nurses, and anaesthetic nurses.

A subsequent clinical pilot research was built on the study’s findings, which were published in Nature Communications.

The first patients in the pilot trial are already being enrolled at Skane University Hospital in Lund. Twenty transplants are included in the trial, half of which will get therapy to reduce cytokine levels and the other half will receive conventional care. If we observe encouraging outcomes, the experiment will be expanded to include 120 transplants nationally, Sandra Lindstedt said. A subsequent clinical pilot research was built on the study’s findings, which were published in Nature Communications.

Scientists are working on next-generation vaccinations since the COVID-19 epidemic seems to never stop, and the top health expert stated that a lot of efforts are being made within the nation for the development of vaccines. According to Dr. NK Arora, the head of the NTAGI COVID-19 working group, “The entire idea behind the next-generation vaccine is that we won’t need to administer additional doses. The second is that if we provide the vaccine, it provides superior coverage for both current and potential future infections, and the protection lasts for a very long time.”

Future viral protection should be possible with the vaccines of the next generation.

He added that some individuals are developing strain-specific vaccinations and that others are attempting to get ready for bivalent viruses, which are viruses that are two or four different types of viruses mixed together.

There are numerous efforts being made across the nation. Some people are working on strain-specific vaccines, while others are attempting to get ready for bivalent viruses, which are viruses that have two or four different strains mixed together. There is an advantage to this, even though it might take some time, Dr. Arora said about the many Covid19 vaccinations that are anticipated in the future.

He added that Indian academics and businesses have taken up the challenge, and additional details will be released over the coming months.

“India, as I mentioned, constantly tries to anticipate events and then get ready. So, let’s consider whether we’re discussing safety measures similarly for next-generation vaccinations. Indian businesses and academia have embraced this issue in line with other worldwide initiatives, and over the coming months, we should learn more about it “Added Dr. Arora.

According to data from the Union Health Ministry, India reported a slight decrease in daily Covid-19 cases on Friday, with 6,168 new infections occurring in the nation over the previous 24 hours.

On Thursday, 7,946 Covid-19 instances were reported nationwide. There are now 59,210 active cases in India.

With 21 additional fatalities in the past day, the death toll has increased to 5,27,932.

The Ministry reports that 4,38,55,365 people nationwide have recovered from COVID after 9,685 individuals did so in the previous 24 hours. At the moment, the recovery rate is 98.68%.

In addition, 22,40,162 doses of the COVID vaccine were provided as part of the national vaccination campaign during this time, bringing the total number of vaccine doses given to far to 212.75 crore.

India reported 7,219 new cases on the previous day, according to information sent on Saturday to the Ministry of Health and Family Affairs.

56,745 instances are now active in India, which represents 0.13 percent of all cases. At the moment, the recovery rate is 98.68%. The number of recoveries increased to 9,651 on the previous day, bringing the total to 4,38,65,016.

The government reported that more than 201.88 crore vaccines have already been given out as part of the statewide COVID-19 vaccination campaign.

The Union Government is dedicated to stepping up and broadening the COVID-19 vaccination programme nationwide. On January 16, 2021, the nationwide COVID-19 immunisation campaign began.

On June 21, 2021, the new phase of COVID-19 vaccination universalism began. The availability of more vaccinations, improved visibility of vaccine availability to States and UTs to enable better planning by them, and streamlining of the vaccine supply chain have all increased the vaccination effort.

The Government of India has been assisting the States and UTs by giving them free COVID vaccines as part of the national vaccination push. The Union Government will purchase and provide (free of charge) to States and UTs 75% of the vaccinations being produced by the country’s vaccine manufacturers as part of the new phase of the COVID19 vaccination drive.